Regulus Therapeutics | Capitale Ordinario

Ordinary Share Capital Cambiamento Data
Alnylam Pharmaceuticals USD 1.26M 4K 2023-12
AstraZeneca USD 387M 0 2023-09
Celldex Therapeutics USD 56K 9K 2023-12
Clal Biotechnology ILS 1.61M 0 2022-12
CSL USD 517M 4.48B 2023-06
Gilead Sciences USD 1000K 0 2023-09
Grifols EUR 119.6M 0 2023-09
Ionis Pharmaceuticals USD 144K 1000 2023-12
Ligand Pharmaceuticals USD 18K 0 2023-12
Takeda JPY 1.68T 92M 2023-09



Regulus Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.